STOCK TITAN

Synergy Chc Corp Stock Price, News & Analysis

SNYR Nasdaq

Welcome to our dedicated page for Synergy Chc news (Ticker: SNYR), a resource for investors and traders seeking the latest updates and insights on Synergy Chc stock.

Synergy CHC Corp. (NASDAQ: SNYR) is a consumer health and wellness company whose news flow centers on brand expansion, retail partnerships, financial results, and capital markets activity. The company develops and markets FOCUSfactor®, a clinically studied brain health supplement and functional beverage line, and Flat Tummy®, a women’s wellness and weight management brand.

News updates for SNYR frequently highlight distribution agreements and retail authorizations for FOCUSfactor® supplements and Focus + Energy functional beverages. Recent press releases describe new Direct Store Delivery partnerships with distributors such as AlaBev, Atlantic Importing Company, C&M Sales, Pine State Beverage, Fuhrer Beverage Company, and Banko Beverage Co., which extend beverage and shot availability across regions including Alabama, Southern New England, Maine, Pennsylvania, and Arkansas. Other announcements cover placements with major retailers like Kroger, Wakefern Food Corp., Uniprix, Fortinos, Pilot Flying J, and PriceSmart.

Investors following SNYR news will also see quarterly earnings announcements, where the company reports revenue, gross margin, operating income, net income, and non‑GAAP metrics such as EBITDA and Adjusted EBITDA. These releases often include commentary on profitability trends, distribution wins, and working capital developments. Additional items include governance and leadership changes, such as board appointments, the creation of roles like Head of Strategic Partnerships, and regional leadership hires for Mexico and Latin America.

Capital markets updates, including public offerings of common stock and related underwriting agreements, appear in both SEC filings and accompanying press releases. For anyone tracking SNYR, this news page provides a consolidated view of the company’s operational progress in brain health and functional beverages, its evolving retail footprint, and key regulatory and financial disclosures. Bookmark this feed to monitor new distribution deals, retailer launches, earnings releases, and corporate developments as they are announced.

Rhea-AI Summary

Synergy CHC Corp. (NASDAQ: SNYR) has announced significant retail and distribution expansions for its FOCUSfactor supplement and beverage lines across North America. The company secured key partnerships with McKesson Canada for national distribution and London Drugs for presence across 80 Western Canada locations.

In the beverage segment, FOCUSfactor's Focus + Energy™ drinks will be launched across 137 Gabe's stores and 34 Old Time Pottery locations. The company will also showcase its beverage line at the 2025 ECRM Beverage Show in Dallas, meeting with buyers representing over 32,000 retail doors.

These developments build upon earlier wins including partnerships with Walmart Canada, Metro Ontario, and Core-Mark, positioning FOCUSfactor for significant market expansion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9%
Tags
none
-
Rhea-AI Summary

Synergy CHC Corp. (NASDAQ: SNYR) has announced significant retail and distribution expansions across North America for its FOCUSfactor supplements and functional beverages. The company secured several major partnerships, including Core-Mark's national authorization for FOCUSfactor Focus + Energy beverages, which will enable distribution to over 50,000 customer locations across the U.S. and Canada.

Key distribution wins include Metro Ontario's launch across 125+ grocery stores and 600 convenience locations, Energy North Group's expansion across New England and Upstate New York, and Downey Wholesale's national distribution network reaching 10,000+ independent retailers. Additionally, Walmart Canada will launch FOCUSfactor supplements nationally in Q4 2025, building on their 18-year U.S. retail partnership.

Product rollouts will begin in Q3 2025 for most partnerships, with the Walmart Canada launch scheduled for Q4 2025. These expansions represent Synergy's most significant growth to date in the brain health and clean energy product categories.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.28%
Tags
none
-
Rhea-AI Summary
Synergy CHC Corp. (NASDAQ: SNYR) has expanded its international licensing agreement with Gravity Pharma to include Turkey alongside the UAE for exclusive distribution of FOCUSfactor®. The deal brings $2 million in upfront licensing revenue plus performance-based royalties from product sales in both markets. The expansion allows Synergy to scale its FOCUSfactor® brand, including brain health supplements, cognitive beverages, and energy shots, while maintaining 100% ownership and global IP. The asset-light growth strategy targets the brain health market, projected to reach $20B by 2030. The company recently strengthened its leadership team with former Coca-Cola global beverage executives to support its growth initiatives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
none
Rhea-AI Summary
Synergy CHC Corp. (NASDAQ: SNYR) has appointed Damian Marano as Vice President of Beverage to drive its FOCUSfactor Energy Drink expansion globally. Marano brings over 20 years of industry experience, notably from Coca-Cola where he managed a $200M ARR portfolio and secured $2B in annual renewals. His track record includes founding Docklight Brands, scaling the Marley wellness portfolio to 25,000+ retail locations across 40+ countries. At Synergy, Marano will focus on expanding the FOCUSfactor Energy Drinks line, which features B-vitamins and nootropics for mental clarity. The company is leveraging its established FOCUSfactor brand presence in major retailers like Costco, Walmart, Amazon, and CVS to penetrate the functional beverage market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
none
-
Rhea-AI Summary
Synergy CHC Corp. (NASDAQ: SNYR) has secured a $20 million term loan credit agreement with ACP Agency, LLC, extending through May 2029. The company received $15 million upfront at SOFR plus 8.5% interest rate, with interest-only payments through 2025. Starting January 2026, quarterly principal payments begin at $175,000, increasing to $350,000 per quarter from 2027. The facility includes a $2.5 million delayed draw facility and $2.5 million uncommitted term loan incremental facility. The refinancing aims to strengthen Synergy's capital structure, repay existing debt, and provide growth capital. The company will use the delayed draw proceeds to fully repay debt related to settlement agreements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.45%
Tags
none
-
Rhea-AI Summary

Synergy CHC Corp. (NASDAQ: SNYR) has appointed Erik Shields as Vice President of Beverage, effective May 26, 2025. Shields brings nearly 20 years of sales leadership experience in both alcoholic and non-alcoholic beverage categories. He previously served as Director of C-Store Sales at Trilliant Food & Nutrition and holds certification as a Cicerone®.

The appointment comes as Synergy expands its flagship brain health brand, FOCUSfactor, into the functional beverage category with the launch of Focus + Energy Drinks. These beverages are formulated with B-vitamins and nootropics for clean energy and focus. In his new role, Shields will lead go-to-market strategy, distribution, and brand execution for this new product line.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.16%
Tags
management
Rhea-AI Summary
Synergy CHC Corp (NASDAQ: SNYR) reported its Q1 2025 financial results, marking its ninth consecutive quarter of profitability. The company achieved a 30% growth in earnings per share to $0.10 compared to $0.08 in Q1 2024. While revenue decreased 13% to $8.2 million from $9.4 million, gross margin improved to 75.4% from 72.0%. Net income increased 51% to $876.3 thousand, and EBITDA grew 7% to $1.98 million. Operating expenses decreased 15% to $4.2 million. The company is pursuing international expansion for its FOCUSfactor brand and Ready-To-Drink beverages into three new markets. Synergy has entered debt refinancing negotiations to extend maturity to 2029, established a subsidiary in Mexico, and signed a new long-term supplier agreement for FOCUSfactor products. The company reduced outstanding liabilities by $1.7 million during Q1 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.31%
Tags
-
Rhea-AI Summary

Synergy CHC Corp. (NASDAQ: SNYR), a consumer health care and lifestyle products provider, has scheduled its Q1 2025 earnings release for Thursday, May 15, 2025, before market opening. The company will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT on the same day.

CEO Jack Ross and CFO Jaime Fickett will lead the conference call. Participants can access the live webcast through Synergy's Investor Relations website and are encouraged to dial in 15 minutes before the start time. A replay will be available on the company's website for a limited time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.93%
Tags
conferences earnings
-
Rhea-AI Summary

Synergy CHC Corp (NASDAQ: SNYR) reported its Q4 and full-year 2024 financial results, marking its eighth consecutive quarter of profitability. Q4 2024 showed revenue of $10.3M (down 22% YoY), with net income of $105.7K and EPS of $0.01. Full-year 2024 results included revenue of $34.8M (down 19% YoY), net income of $2.1M, and EPS of $0.28.

The company completed its IPO in October 2024, offering 1,150,000 shares at $9.00 per share. Notable developments include expanded partnerships with BJ's Wholesale Clubs and Publix, reduced debt by $4.5M in Q4, and the appointment of Jaime Fickett as permanent CFO. The revenue decline was primarily attributed to FOCUSfactor rebranding and retailer de-inventorying, which the company states is now behind them as they enter 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.97%
Tags
Rhea-AI Summary

Synergy CHC Corp. (NASDAQ: SNYR), a consumer health care and lifestyle products provider, has scheduled the release of its Q4 and full year 2024 financial results for Monday, March 31, 2025, before market opening.

The company will host a conference call at 9:00 a.m. ET / 6:00 a.m. PT on the same day, featuring CEO Jack Ross and CFO Jaime Fickett. Participants are encouraged to join 15 minutes before the start time. The call will be accessible through a live webcast on Synergy's Investor Relations website, with a replay available for a time.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.85%
Tags
conferences earnings

FAQ

What is the current stock price of Synergy Chc (SNYR)?

The current stock price of Synergy Chc (SNYR) is $0.3905 as of May 8, 2026.

What is the market cap of Synergy Chc (SNYR)?

The market cap of Synergy Chc (SNYR) is approximately 5.9M.